July 13, 2021 /PRNewswire/ -- Amyris,
Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company
active in the Clean Health, Beauty and Wellness markets through its
consumer brands and a top supplier of sustainable and natural
ingredients, today released its first Environmental, Social and
Governance (ESG) report, underscoring the company's founding
commitment to making people and the planet healthier.
With its leading Lab-to-Market™ science and technology, Amyris
translates biotechnology into new applications and products that
consumers love and that enable the transition of many industries to
sustainable chemistry. This inaugural ESG report communicates the
company's progress and baseline for measurement of Amyris' ESG
Amyris' ESG report is aligned with leading sustainability
frameworks and reporting standards, including the Sustainability
Accounting Standards Board (SASB) framework, select disclosures
from the Global Reporting Initiative's (GRI) framework, and select
goals from the United Nations Sustainable Development Goals
"Sustainability is at the core of everything we do and as our
success continues to accelerate, so too will the health benefits
for people and the planet," said John
Melo, CEO and President of Amyris. "The future of health,
wellness and beauty is clean chemistry. This report provides deeper
transparency and accountability into our vision as we lead the way
for consumers and our industry partners. Our mission is to move the
world to sustainable consumption as the leading supplier of clean
ingredients, with top performing consumer brands in their
respective categories. This ESG report shows our continued progress
and commitment to a better future for all."
"Publishing our first ESG report is an important step in
communicating the meaningful impact that Amyris is making," said
Beth Bannerman, Chief Engagement and
Sustainability Officer. "We are deeply committed to our ESG agenda
and will continue to push the boundaries of sustainable innovation,
driven by our proprietary Lab-to-MarketTM science and
technology, delivering best-in-class, natural and
sustainably-sourced ingredients with distinctive consumer-inspired
Amyris' inaugural ESG report primarily covers 2020 performance,
including the company's response to the COVID-19 pandemic. The
report details how the company focused on this priority while
maintaining business continuity and having one of the most
productive years to date.
Key highlights from the report include:
- Amyris received the Bonsucro Chain of Custody Certification,
ensuring that its primary feedstock of Brazilian sugarcane is
sustainably and ethically produced.
- Amyris' sustainably sourced, natural ingredients are formulated
in over 20,000 products and reach over 300 million consumers.
- Amyris' Biossance brand products are all verified by the
Environmental Working Group (EWG), meeting their strict health
- 90% of hazardous lab waste in the Emeryville, CA headquarters is recycled.
- Of the employees who received a promotion in 2020 at Amyris,
54% identified as female.
- In response to COVID-19, Amyris activated its Emergency
Response Plan prioritizing the health and safety of employees and
the communities in which it operates. This included the
donation of over 20,000 32-ounce units of Pipette branded hand
sanitizer to frontline healthcare workers.
In addition to the launch of its ESG report, Amyris has also
announced its ESG impact goals for realizing a sustainable future.
These goals have depth and breadth with ambitious timelines to
positively impact the triple bottom line.
- Environment: Net Zero by 2030
- Social: 100% Engagement in Community Improvement by 2024
- Governance: 100% of Amyris Partners adopt the Amyris
"Partnership Pledge to the Planet" by 2023
"We need to set a higher standard and be bold when we set our
goals," Mr. Melo said. "We need these goals to deliver a
demonstrable impact in the near term, consistent with our focus on
delivering healthier solutions for both people and planet."
Visit the Amyris website to download the 2020 ESG Report.
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris is proud to own
and operate a family of consumer brands - all built around its No
Compromise® promise of clean ingredients: Biossance® clean beauty
skincare, Pipette® clean baby skincare, and Purecane™, a
zero-calorie sweetener naturally derived from sugarcane. For more
information, please visit http://www.amyris.com.
This release contains
forward-looking statements, and any statements other than
statements of historical fact could be deemed to be forward-looking
statements. These forward-looking statements include, among other
things, Amyris's ESG impact goals and the timing thereof. These
statements are based on management's current expectations and
actual results and future events may differ materially due to risks
and uncertainties, including risks related to delays or failures in
development, regulatory approval, production and commercialization
of products; risks related to Amyris's reliance on third parties
(including in the supply chain); Amyris's liquidity and ability to
fund operating and capital expenses; and other risks detailed from
time to time in filings Amyris makes with the Securities and
Exchange Commission, including Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Amyris disclaims any obligation to update information contained in
these forward-looking statements, whether as a result of new
information, future events, or otherwise.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
SOURCE Amyris, Inc.